ChronoScale Holdings Corp
No SEC Form 4 filings for $CHRN in the last 30 days.
See all $CHRN insider activity →ChronoScale Holdings (CHRN) shares fell 11.1% to $15.90 on Tuesday, erasing gains from a $1 billion contract announcement earlier in October. The decline was part of a broader tech sell-off, with no company-specific news released. ChronoScale, valued at $2.3 billion, focuses on AI computing infrastructure and has seen significant volatility over the past year.
ChronoScale announced Scott Davis's resignation from its board, effective October 3, 2026, following the sale of its subsidiary Ekso. Davis, who served as Ekso's CEO, received 51,626 fully vested RSUs and a $709,500 lump-sum payment. The resignation was part of a release agreement, with no changes to his Phantom Performance-Based RSU Agreement.
ChronoScale Holdings Corp (CHRN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Board Resignation of and Release Agreement with Mr. Davis As previously announced, on September 30, 2026, ChronoScale Hold
Over the past 7 days, AlphAI's AI scored 1 news story mentioning CHRN (ChronoScale Holdings Corp). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent CHRN coverage spans corporate actions, market movers and technology.
Likely downside pressure as the market re-prices AI-infrastructure risk amid broader tech and semiconductor weakness, despite prior contract optimism.
Board resignation with a sizable severance may raise governance concerns and modest short‑term sell pressure.
The departure of a director and associated severance may cause modest downside pressure as investors reassess governance and leadership continuity.
Analyst buy and target above current price may support the stock.
Potential short‑term pressure as market assesses leadership change at Ekso subsidiary.
AlphAI scores every news story that mentions CHRN with an AI model for sentiment and relevance, and aggregates insider trades from ChronoScale Holdings Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
ChronoScale Holdings (CHRN) shares fell 11.1% to $15.90 on Tuesday, erasing gains from a $1 billion contract announcement earlier in October. The decline was part of a broader tech sell-off, with no company-specific news released. ChronoScale, valued at $2.3 billion, focuses on AI computing infrastructure and has seen significant volatility over the past year.
7 min readChronoScale announced Scott Davis's resignation from its board, effective October 3, 2026, following the sale of its subsidiary Ekso. Davis, who served as Ekso's CEO, received 51,626 fully vested RSUs and a $709,500 lump-sum payment. The resignation was part of a release agreement, with no changes to his Phantom Performance-Based RSU Agreement.
1 min readChronoScale Holdings Corp (CHRN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Board Resignation of and Release Agreement with Mr. Davis As previously announced, on September 30, 2026, ChronoScale Hold
1 min readAnalysts from Jefferies and Northland Securities reiterated Buy ratings on ServiceNow (NOW) and Gorilla Technology Group (GRRR), with price targets of $140 and $40, respectively. ServiceNow's consensus target is $143.41, a 4.1% upside. Gorilla Technology's consensus target is $34.60. ChronoScale (CHRN) also received a Buy rating with a $32 target.
2 min readChronoScale terminated Ekso COO Jason C. Jones on September 30, 2026, following the sale of Ekso. He received a severance package including $243,750 in cash and up to nine months of COBRA benefits, subject to a release agreement. Jones's Phantom Performance-Based RSU Agreement remains in effect.
1 min readChronoScale Holdings Corp (CHRN) reported the sale of its subsidiary, Ekso Bionics, and a severance agreement with its COO, Jason C. Jones, who will receive $243,750 and COBRA coverage. The company also withdrew the designation of its Series B Convertible Preferred Stock. Additionally, ChronoScale announced a press release about expanding an AI infrastructure agreement, aiming to reach $1 billion in annualized revenue run rate by Q3 2027.
2 min readChronoScale Holdings Corp (CHRN) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Next-Gen Hybrid AI ChronoScale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue to $1 Billion and Sale of Ekso Bionics Business Unit ● Expanded agreement with an existing AI infrastructure customer and new customer agreement increases contracte
2 min readChronoScale (NASDAQ: CHRN) announced new AI infrastructure agreements, expected to drive its annualized revenue run rate to $1 billion by Q3 2027. The company also completed the sale of its Ekso Bionics business unit to focus on its core AI infrastructure business. ChronoScale's CEO highlighted the importance of these agreements in validating demand and growing alongside customers.
2 min readOn 25 September 2026, PPLI surged 11.33% to $40.00, ALM rose 10.65% to $13.72, and MXL climbed 10.00% to $93.84. Meanwhile, ZS fell 10.06% to $193.05, and TWLO dropped 7.96% to $275.80. Volatility was noted in small- and mid-cap stocks, with semiconductors and mining gaining, while cybersecurity and fintech declined.
1 min readChronoScale (CHRN) and Ekso Bionics amended a $2.0M term loan with B. Riley, extending its maturity to November 2026 and allowing potential sale of the guarantor, preserving other terms.
1 min read
